Risk for Alzheimer’s dementia lower with treated versus untreated HTN
Aug 14, 2024
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
CCRC program bridges gap between assisted living, memory care for residents
By
Kimberly Bonvissuto
Aug 14, 2024
A full memory support program with a growing waiting list prompted one continuing care retirement / life plan community to create a program that bridges the gap between assisted living and full memory...
HbA1c stability tied to lower risk for Alzheimer disease and related dementias
Aug 08, 2024
The findings were seen in a large study of older veterans with diabetes.
Government support of dementia caregiving across the continuum important: poll
By
Kimberly Bonvissuto
Aug 06, 2024
A recent poll of more than 1,000 older adults found they overwhelmingly want the government to support dementia care across the care continuum, including in assisted living settings.
Digital cognitive impairment assessment tool earns validation
By
Donna Shryer
Aug 06, 2024
New research presented at the Alzheimer’s Association International Conference (AAIC) provided validation for BrainCheck, a digital cognitive assessment tool. Researchers from the University of Washington...
COVID-19 continues to affect leading causes of death in US: CDC
By
Kimberly Bonvissuto
Aug 12, 2024
The COVID-19 pandemic radically altered the rankings of the leading causes of death in the United States in 2020, and although COVID ranks lower on the list of causes in 2023, its effects continue to be...
Alzheimer’s care, quality of life improve with innovative immersion room
By
Jessica R. Towhey
Aug 05, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of Alzheimer’s care.
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.